Single Oral Dose of Bevenopran in Patients With Varying Degrees of Renal Impairment

Stopped Development of compound has been put on hold.

Conditions

• Renal Impairment

Interventions

• DRUG: bevenopran

Sponsor

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Collaborators

• [object Object]